Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 309.40
-10.60 (-3.31%)
Apr 17, 2026, 2:46 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 28.84 billion as of April 16, 2026.
Market Cap
28.84B
Enterprise Value
25.26B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
309.40
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 28.84B, an increase of 64.69%. That is a compound annual growth rate of 64.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 28.84B | 8.18% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 45.43B |
| Shanghai Henlius Biotech | 45.14B |
| InnoCare Pharma | 32.25B |
| Genscript Biotech | 30.09B |
| Shanghai Bao Pharmaceuticals | 28.69B |
| TransThera Sciences (Nanjing) | 27.77B |
| Keymed Biosciences | 23.77B |
| Zai Lab | 20.52B |